Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants

NCT05030012 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped No path to obtain FDA approval for the legacy Precision Flow OAM.

Conditions

Infant, Premature
Neonatal Respiratory Distress
Oxygen Saturation
Bronchopulmonary Dysplasia

Interventions

DEVICE: Automated Control
DEVICE: Manual Control

Sponsor

Vapotherm, Inc.

Collaborators

[object Object]
[object Object]
[object Object]